AstraZeneca's diabetes drug Xigduo approved in Europe
LONDON (Reuters) - AstraZeneca said European regulators had approved Xigduo for type 2 diabetes, in what was the first green light for a fixed dose co...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/eRNLO2L1SSA/story01.htm
No comments:
Post a Comment